▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Sherwin-Williams Co Q4 22 Earnings Conference Call At 11:00 AM ET

By RTTNews Staff Writer ✉ | Published: 1/26/2023 10:01 AM ET

Sherwin-Williams Co. (SHW) will host a conference call at 11:00 AM ET on January 26, 2023, to discuss Q4 22 earnings results.

To access the live webcast, log on to https://investors.sherwin-williams.com/financials/quarterly-results/

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche

Read More

COVID-19: Drugs in Development

RELATED NEWS

Sherwin-Williams Issues Q2 Revenue View, Backs FY23 Forecast; Stock Up In Pre-market

Sherwin-Williams Co Q1 Profit Increases, beats estimates

Sherwin-Williams Signs Deal To Divest China Architectural Paint Business

Follow RTT

Editor's Pick
Most Read
Most Emailed

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Macy's, Dollar General Q1 Profits Decline

FDA Warns Retailers Against Illegal Sales Of Disposable E-cigarettes

Tillamook Recalls Certain Waffle Cone Swirl Ice Cream Packaged In Chocolate Peanut Butter Carton

Mattel Unveils New Barbie The Movie Collection

Rudolph's OnYums Onion Flavored Rings Sold At Dollar Tree Recalled

Krispy Kreme, Dunkin' To Offer Free Donuts On National Doughnut Day

Cricket Creek Farm Recalls Sophelise And Tobasi Cheeses

Carvana Up 12%; Gets 'notable S&P Global Ratings Upgrades"

Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints

U-Haul Holding Shares Down On Lower Earnings In Q4

Seagen To Be Acquired By Pfizer For $43 Bln

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

Magnachip To Spin-off Display And Power Businesses Into Separate Entities

Macy's Q1 Profit Down, But Beats Estimates; Cuts Annual Earnings Guidance Below View - Update

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

ACI Worldwide Appoints Thomas Warsop As New CEO

Trevena Achieves Listing Compliance On Nasdaq

Alterity Therapeutics Granted Initial Approval For Phase 2 Clinical Trial Of ATH434

Hunting Wins $91 Mln OCTG Order From Cairn Oil And Gas, Vedanta; Lifts FY23 EBITDA View

Constellation To Acquire NRG's 44% Stake In South Texas Project Electric Generating Station

Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease

Former Wells Fargo Executive Tolstedt Agrees To Settle SEC Fraud Charges

Hormel Foods Reaffirms FY23 Outlook - Update

8x8 Names Samuel Wilson CEO

Svenska Handelsbanken To Sell Certain Operations In Finland

Hewlett Packard Enterprise Q2 Profit Increases, beats estimates

CAE Q4 Earnings Spike

Guy Carpenter To Buy Israeli Insurance Broker Re Solutions For Undisclosed Sum

Dechra Pharma Agrees To Be Acquired By EQT's Freya Bidco For 3,875p/share In Cash

WH Smith 13-week Group Revenue Rises; Says Full-year Expectations Modestly Improved